Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection
- PMID: 35994281
- PMCID: PMC9396467
- DOI: 10.1001/jama.2022.15336
Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection
Plain language summary
This case series describes the clinical resolution of systemic symptoms and lesions, along with any adverse events, in patients with monkeypox infection who were treated with tecovirimat on a compassionate use basis.
Conflict of interest statement
References
-
- Adler H, Gould S, Hine P, et al. ; NHS England High Consequence Infectious Diseases (Airborne) Network . Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153-1162. doi:10.1016/S1473-3099(22)00228-6 - DOI - PMC - PubMed
-
- CDC . 2022 Monkeypox outbreak global map. July 27, 2022. Accessed July 28, 2022. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
